P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS AND SUBGROUP ANALYSIS FROM THE PHASE 1/2 BRUIN STUDY WITH >3 YEARS FOLLOW-UP FROM START OF ENROLLMENT

ABSTRACT:

SUBMITTER: Jurczak W 

PROVIDER: S-EPMC10431019 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature